different strength [Design Issues]

posted by ioanam – Romania, 2007-03-18 01:27 (7029 d 21:38 ago) – Posting: # 584
Views: 5,070

Dear Sir,
I have to perform a bioequivalence study with two strengths (120 mg and 160 mg) for a modified release formulation, which are not dose proportional. The Orange book specifies only 160 mg formulation as RLD. There is also an innovator for 120 mg, but it is not listed as RLD. In that case what shall be the reference drug for 120mg strength?
Thank you.

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
138 visitors (0 registered, 138 guests [including 21 identified bots]).
Forum time: 00:06 CEST (Europe/Vienna)

The idea is to try and give all the information to help others
to judge the value of your contribution;
not just the information that leads to judgment
in one particular direction or another.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5